Samumed, LLC

Release Summary

SAMUMED RECEIVES ORPHAN DRUG DESIGNATION FROM FDA FOR SM04646 AS A TREATMENT FOR IDIOPATHIC PULMONARY FIBROSIS (IPF)

Samumed, LLC